This analysis explores the principal regulatory concerns linked to nanomedicines and gene
vaccines, including the complexities involved and the perspectives on how to navigate them …

Simple Summary Although immune check point inhibitors have been established as a new
paradigm in cancer treatment, they have shown no clinical benefit in immune excluded or …

The concept of DNA vaccination was introduced in the early 1990s. Since then,
advancements in the augmentation of the immunogenicity of DNA vaccines have brought …

Immuno-oncology has revolutionized cancer treatment and has opened up new
opportunities for develo** vaccination methods. DNA-based cancer vaccines have …

Dendritic cells (DCs) are professional antigen-presenting cells that play a key role in
sha** adaptive immunity. DCs have a unique ability to sample their environment, capture …

Cancer immunotherapies refer to the concept of retraining the immune system to target
malignant cells. Multiple immunotherapeutic options exist including immune modulating …

Cancer vaccine gains great attention with the advances in tumor immunology and
nanotechnology, but its long-term efficacy is restricted by the unsustainable immune activity …

Introduction: Clinical trials are the gold standard for testing new therapies. Databases like
ClinicalTrials. gov provide access to trial information, mainly covering the US and Europe. In …

Advances in melanoma research have unveiled critical insights into its genetic and
molecular landscape, leading to significant therapeutic innovations. This review explores the …

Peptide antigens derived from tumors have been observed to elicit protective immune
responses, categorized as either tumor-associated antigens (TAAs) or tumor-specific …